Study of endothelial dysfunction in patients of psoriatic arthritis by flow mediated and nitroglycerine mediated dilatation of brachial artery

International Journal of Rheumatic Diseases

Volumn 19, Issue 3, 2016, Pages 300-304

  Sharma, Aman ^a   Reddy, Mallapu Hithesh ^a   Sharma, Kusum ^a   Dogra, Sunil ^a   Vijayvergiya, Rajesh ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Cardiovascular morbidity; Endothelial dysfunction; Endothelial dependent flow mediated vasodilatation; Endothelial independent nitroglycerine mediated vasodilatation; Flow mediated vasodilatation; Psoriatic arthritis

Indexed keywords

GLYCERYL TRINITRATE; VASODILATOR AGENT;

ADULT; ARTERY DILATATION; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; FLOW MEDIATED DILATATION; HUMAN; MALE; NITROGLYCERIN MEDIATED DILATATION; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RISK FACTOR; BLOOD FLOW; CASE CONTROL STUDY; DIAGNOSTIC IMAGING; ECHOGRAPHY; HYPEREMIA; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; VASCULAR ENDOTHELIUM; VASODILATATION; YOUNG ADULT;

ADULT; ARTHRITIS, PSORIATIC; BRACHIAL ARTERY; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPEREMIA; MALE; MIDDLE AGED; NITROGLYCERIN; PREDICTIVE VALUE OF TESTS; REGIONAL BLOOD FLOW; RISK FACTORS; ULTRASONOGRAPHY; VASODILATION; VASODILATOR AGENTS; YOUNG ADULT;

EID: 84897349608     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12336     Document Type: Article

References (15)

1. Wong K, Gladman DD, Husted J, Long JA, Farewell VT (1997) Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum 40, 1868-72.
2. Bedi TR (1995) Clinical profile of psoriasis in North India. Indian J Dermatol Venereol Leprol 61, 202-5.
3. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB (2006) Risk of myocardial infarction in patients with psoriasis. JAMA 296, 1735-41.
4. Tam LS, Tomlinson B, Chu TT et al. (2008) Cardiovascular risk profile of patients with psoriatic arthritis compared to controls-the role of inflammation. Rheumatology (Oxford) 47, 718-23.
5. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54, 2665-73.
6. Moll JM, Wright V (1973) Psoriatic arthritis. Semin Arthritis Rheum 3, 55-78.
7. Tyldum EV, Madssen E, Skogvoll E, Slørdahl SA (2008) Repeated image analyses improves accuracy in assessing arterial flow-mediated dilatation. Scand Cardiovasc J 42, 310-5.
8. Gonzalez-Juanatey C, Llorca J, Miranda-Filloy JA et al. (2007) Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 57, 287-93.
9. Sarkissian T, Beyenne J, Feldman B, Adeli K, Silverman E (2006) The complex nature of the interaction between disease activity and therapy on the lipid profile in patients with pediatric systemic lupus erythematosus. Arthritis Rheum 54, 1283-90.
10. Gisondi P, Tessari G, Conti A et al. (2007) Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 157, 68-73.
11. Kimhi O, Caspi D, Bornstein NM et al. (2007) Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum 36, 203-9.
12. Sharma A, Gopalakrishnana D, Kumar R, Vijayvergiya R, Dogra S (2013) Metabolic syndrome in psoriatic arthritis patients: a cross-sectional study. Int J Rheum Dis 16, 667-73.
13. Vaudo G, Marchesi S, Gerli R et al. (2004) Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis 63, 31-5.
14. Mazzoccoli G, Notarsanto I, de Pinto GD, Dagostino MP, De Cata A, D'Alessandro G (2010) Anti-tumor necrosis factor-alpha therapy and changes of flow-mediated vasodilatation in psoriatic and rheumatoid arthritis patients. Intern Emerg Med 5, 495-500.
15. Bergholm R, Leirisalo-Repo M, Vehkavaara S, Makimattila S, Taskinen MR, Yki-Jarvinen H (2002) Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis. Arterioscler Thromb Vasc Biol 22, 1637-41.